NVS

Novartis AG
D

NVS

98.980
USD
-0.80
(-0.80%)
Market Open
Volume
15,735
EPS
8
Div Yield
3.75
P/E
17
Market Cap
197,887,747,866
OverviewSignalsIdeasNews
Related Instruments
    ABBV
    ABBV
    -2.480
    (-1.44%)
    169.890 USD
    GSK
    GSK
    -0.160
    (-0.47%)
    33.620 USD
    JNJ
    JNJ
    -4.765
    (-3.22%)
    143.400 USD
    LLY
    LLY
    10.37
    (1.40%)
    753.61 USD
    MRK
    MRK
    -0.480
    (-0.50%)
    95.750 USD
    PFE
    PFE
    -0.276
    (-1.04%)
    26.355 USD
    SNY
    SNY
    -0.200
    (-0.39%)
    51.480 USD
    VRTX
    VRTX
    1.06
    (0.25%)
    429.07 USD
    More
News

Title: Novartis AG

Sector: Healthcare
Industry: Drug Manufacturers - General
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.
Trading. Social. Simple.
FacebookTwitterYoutube
Company
Contact usAbout usTerms Of UsePrivacy PolicyCookies PolicyDisclaimerHelp Center
Social Network
The NetworkSignals NetworkIdeas NetworkBest Traders
Products
Risk CalculatorPip CalculatorAdvance Chart
Markets
Exchange RatesCommodities RatesCryptocurrencies RatesIndices RatesUS Stocks Rates
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.